Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

Feb. 16 (UPI) --An Ohio man who stuck with the same set of lottery numbers for 22 years found his persistence rewarded with a $3.5 million jackpot. The Akron man told Ohio Lottery officials he kept ...

Boxes of Junk Wax Era cards remain plentiful. Jason J. Molyet/News Journal / USA TODAY NETWORK via Imagn Images As a serial over-analyzer of Topps odds, one of the most common comments I hear is that ...

Imre Szenttornyay, CEO of Cielo IT LLC, empowers business owners to scale their operations profitably with AI-powered SmartSigns technology. When you manage a network of retail or franchise locations, ...

Much attention has been focused on Donald Trump’s use of words — that is, his peculiar style of oratory. But more attention should be paid to another feature of his discourse: his use of numbers.

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

With the holidays are just around the corner, your savings might be taking a hit. Why not take a shot at one of the year's biggest Powerball jackpots? Saturday's prize has reached $1 billion and while ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

After three years of unprecedented tech spending and nonstop hype, the demand for AI in the workplace seems to be drying up fast. Looking at the big picture doesn’t make it any prettier. Back in March ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...